
Wisconsin Investment Partners
Description
Wisconsin Investment Partners (WIP) is a prominent angel investment group based in Madison, Wisconsin, established in 2000. As one of the longest-standing angel networks in the state, WIP plays a crucial role in fostering the growth of early-stage companies within the Wisconsin ecosystem. The group comprises experienced investors and entrepreneurs dedicated to providing capital and strategic guidance to promising ventures, contributing significantly to the regional startup landscape.
WIP primarily focuses on Wisconsin-based companies exhibiting high-growth potential, strong management teams, large addressable markets, and proprietary technology. Their investment thesis centers on supporting innovative startups that can significantly impact their respective industries. Since its inception in 2000, Wisconsin Investment Partners has deployed over $15 million across more than 50 companies, demonstrating a consistent commitment to the regional startup community. This significant capital deployment underscores their active participation in multiple funding rounds over two decades.
The group's portfolio includes notable successes such as gener8tor, a nationally recognized accelerator, and Propeller Health, a digital health company acquired by ResMed. These investments highlight WIP's ability to identify and back companies that achieve substantial exits and contribute to the economic vitality of the region. WIP's typical investment range for a company is between $100,000 and $500,000, reflecting their role in seed and early-stage funding rounds, often alongside other angel investors or venture capital firms. Their long-term presence and strategic investments have made them a cornerstone of the Wisconsin angel investment landscape.
Investor Profile
Wisconsin Investment Partners has backed more than 117 startups, with 0 new investments in the last 12 months alone. The firm has led 18 rounds, about 15% of its total and boasts 11 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series Unknown, Seed, Series A rounds (top funding stages).
- Majority of deals are located in United States, Canada, Slovakia (Slovak Republic).
- Strong thematic focus on Biotechnology, Health Care, Medical.
- Typical check size: $100K – $500K.
Stage Focus
- Series Unknown (38%)
- Seed (26%)
- Series A (9%)
- Angel (9%)
- Debt Financing (7%)
- Series B (5%)
- Pre Seed (2%)
- Post Ipo Equity (1%)
- Series C (1%)
- Grant (1%)
Country Focus
- United States (97%)
- Canada (2%)
- Country not foundSlovakia (Slovak Republic) (1%)
Industry Focus
- Biotechnology
- Health Care
- Medical
- Software
- Manufacturing
- Medical Device
- Pharmaceutical
- Therapeutics
- Mobile
- E-commerce
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.